374 related articles for article (PubMed ID: 29794127)
1. Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model.
Vannocci T; Notario Manzano R; Beccalli O; Bettegazzi B; Grohovaz F; Cinque G; de Riso A; Quaroni L; Codazzi F; Pastore A
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29794127
[TBL] [Abstract][Full Text] [Related]
2. The role of frataxin in fission yeast iron metabolism: implications for Friedreich's ataxia.
Wang Y; Wang Y; Marcus S; Busenlehner LS
Biochim Biophys Acta; 2014 Oct; 1840(10):3022-33. PubMed ID: 24997422
[TBL] [Abstract][Full Text] [Related]
3. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
Anzovino A; Lane DJ; Huang ML; Richardson DR
Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
[TBL] [Abstract][Full Text] [Related]
5. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells.
Kemp K; Dey R; Cook A; Scolding N; Wilkins A
Cerebellum; 2017 Aug; 16(4):840-851. PubMed ID: 28456899
[TBL] [Abstract][Full Text] [Related]
9. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
Gomes CM; Santos R
Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
[TBL] [Abstract][Full Text] [Related]
11. No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells.
Steinkellner H; Singh HN; Muckenthaler MU; Goldenberg H; Moganty RR; Scheiber-Mojdehkar B; Sturm B
Gene; 2017 Jul; 621():5-11. PubMed ID: 28412459
[TBL] [Abstract][Full Text] [Related]
12. Friedreich's ataxia.
Alper G; Narayanan V
Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
[TBL] [Abstract][Full Text] [Related]
13. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.
Chiang S; Kovacevic Z; Sahni S; Lane DJ; Merlot AM; Kalinowski DS; Huang ML; Richardson DR
Clin Sci (Lond); 2016 Jun; 130(11):853-70. PubMed ID: 27129098
[TBL] [Abstract][Full Text] [Related]
14. Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.
Rufini A; Fortuni S; Arcuri G; Condò I; Serio D; Incani O; Malisan F; Ventura N; Testi R
Hum Mol Genet; 2011 Apr; 20(7):1253-61. PubMed ID: 21216878
[TBL] [Abstract][Full Text] [Related]
15. Friedreich's ataxia: the vicious circle hypothesis revisited.
Bayot A; Santos R; Camadro JM; Rustin P
BMC Med; 2011 Oct; 9():112. PubMed ID: 21985033
[TBL] [Abstract][Full Text] [Related]
16. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
17. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
[TBL] [Abstract][Full Text] [Related]
18. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
Tan G; Chen LS; Lonnerdal B; Gellera C; Taroni FA; Cortopassi GA
Hum Mol Genet; 2001 Sep; 10(19):2099-107. PubMed ID: 11590127
[TBL] [Abstract][Full Text] [Related]
19. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Prospects for Friedreich's Ataxia.
Zhang S; Napierala M; Napierala JS
Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
